Company: BIAF
Filing Date: 2025-09-30
Form Type: 8-K
Source: 0001493152-25-016366
Chunk: 1

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-30
Form: 8-K
Item: Item 8.01
Chunk 1
---
, the Company received written notice from the Staff that it had not regained compliance with the Minimum Bid Price Requirement
by August 6, 2025, and was not eligible for a second 180-day compliance period as the Company did not comply with the minimum stockholders’
equity requirement for initial listing on the Nasdaq Capital Market. As a result, unless the Company requested an appeal to a hearings
panel (the “ Panel”) by August 14, 2025, its securities would be scheduled for delisting from The Nasdaq Capital Market and
would be suspended at the opening of business on August 18, 2025. The Company submitted
an appeal to Nasdaq on August 14, 2025, which will stay the delisting and suspension of the Company’s securities pending the decision
of the Panel. On August 14, 2025, the Company received written notice from Nasdaq that its hearing has been scheduled for September 11,
2025. At the hearing, the Company presented its views and its plans to regain compliance with the Minimum Bid Price Requirement and the
Continued Listing Equity Requirement to the Panel. On September 18, 2025, Nasdaq granted the Company an extension until October 2, 2025,
to demonstrate compliance with the Minimum Bid Price Requirement and Continued Listing Equity Requirement.

  -3-  

As
previously reported in a Current Report on Form 8-K, on August 13, 2025, the Company completed a private placement and warrant inducement
transaction which resulted in gross proceeds to the Company of approximately $1.2 million.

As
previously reported in a Current Report on Form 8-K, on September 17, 2025, the Company filed with the Secretary of State of the State
of Delaware a certificate of amendment to its certificate of incorporation (the “ Certificate of Amendment”) to effect a one-for-thirty
(1-for-30) reverse stock split. The reverse stock split became effective as of 4:01 p. m. Eastern Time on September 18, 2025, and the
Company’s common stock began trading on a split-adjusted basis when The Nasdaq Capital Market opened on September 19, 2025. The
reverse stock split is primarily intended to bring the Company into compliance with Nasdaq’s Minimum Bid Price Requirement. As
of the date of filing of this Current Report on Form 8-K, the Company has maintained compliance with Nasdaq’s Minimum